Federal grants to Curi Bio Inc
Curi Bio Inc in Seattle, Washington received $7.4 million in federal grants from fiscal 2021 to 2025, across 4 awards. Its largest program was National Center for Advancing Translational Sciences, with $4.4 million. In fiscal 2025 it was awarded $2.1 million.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$7.4 million
- Awards4
- Awarded in FY 2025$2.1 million
- Largest award$2.3 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 2 | $1.7 million |
| FY 2022 | 1 | $1.1 million |
| FY 2023 | 3 | $769,570 |
| FY 2024 | 2 | $1.7 million |
| FY 2025 | 2 | $2.1 million |
Programs that fund Curi Bio Inc
| Program | Awards | Amount |
|---|---|---|
| National Center for Advancing Translational Sciences | 2 | $4.4 million |
| Cardiovascular Diseases Research | 2 | $3.0 million |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 4 | $7.4 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| A cross-species preclinical platform to enhance the translation of new medicines - project description duchenne muscular dystrophy (DMD) is a lethal, x-linked recessive disorder with no known cure that afflicts 1 in 5,000 newborn males. Patients carry a mutation in the dystrophin (DMD) gene, resulti | National Center for Advancing Translational Sciences | May 31, 2023 | $2.3 million |
| High-throughput nmj assay for botox potency screening - project summary the botulinum toxin potency assay using tissue chips program from fda and ncats highlights the need for novel engineered systems capable of reliably evaluating botulinum toxin (BOT) potency. Human induced pluripotent stem cell ( | National Center for Advancing Translational Sciences | August 1, 2023 | $2.1 million |
| Predictive assessment of acute and chronic cardiotoxicity using combinatorially matured hpsc-cms | Cardiovascular Diseases Research | September 2, 2021 | $2.0 million |
| Bioengineering mature human pluripotent stem cell-derived cardiomyocytes for predictive drug-induced toxicity testing | Cardiovascular Diseases Research | February 23, 2021 | $993,756 |
Questions people ask
How much federal grant money does Curi Bio Inc get?
$7.4 million in 4 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Curi Bio Inc the most?
The Department of Health and Human Services, with $7.4 million in 4 awards.
What is Curi Bio Inc's largest federal grant?
$2.3 million under National Center for Advancing Translational Sciences, with its first action in the period on May 31, 2023. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Curi Bio Inc?
Its largest are National Center for Advancing Translational Sciences and Cardiovascular Diseases Research.
Other grant recipients in Seattle
- University of Washington
- Central Puget Sound Regional Transit Authority
- Fred Hutchinson Cancer Center
- King County Metro Transit
- Port of Seattle
- Seattle Children's Hospital
- Allen Institute
- Seattle Housing Authority
Largest federal grant recipients in Washington · Federal grants in Washington